Ubrelvy 100 MG tablet UD 16S
Ended Awarded
- Contract number
- SPE2DX25F6TKE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $9,659
Award facts
- Contract value 100% obligated
- $9,658.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of UBRELVY (ubrogepant) 100 mg tablets in unit dose packaging, 16-count configuration. This competitively awarded, non-set-aside delivery order carries a ceiling value of $9,658.97 with firm fixed pricing and an ultimate completion date of August 18, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under a child contract relationship, likely stemming from AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for the company's pharmaceutical supply support to federal military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical commodities to the Department of Defense and related federal healthcare entities. The company maintains an extensive portfolio of federal contract awards covering a wide range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. UBRELVY is a migraine treatment medication, and its procurement under this delivery order supports the ongoing pharmaceutical supply needs of military and veteran healthcare systems served through the Defense Logistics Agency's comprehensive medical supply chain.
Quick answers
Who was awarded contract SPE2DX25F6TKE?
SPE2DX25F6TKE was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 15, 2025.
How much is contract SPE2DX25F6TKE worth?
The government has obligated $9,659 on SPE2DX25F6TKE.
Is contract SPE2DX25F6TKE an order under another contract?
Yes. SPE2DX25F6TKE is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6TKE competed?
The extent of competition for SPE2DX25F6TKE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award